Active Stocks: Genworth Financial, Inc. (NYSE:GNW), Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM), RSP Permian, Inc. (NYSE:RSPP),

Genworth Financial, Inc. (NYSE:GNW) declared that its previously revealed preliminary anticipates of the additional capital need to meet the PMIERs guidelines in their current form. The firm now estimate that the amount of additional capital required to meet these guidelines and operate business will be between $500 million and $700 million (Prior $450-550 mln) as of June 30, 2015. Genworth Financial, Inc. (NYSE:GNW) Trend Analysis begun last trade with a price of $8.12 and throughout the trading session climbed at a high of $8.46. The day-trade ended with 3.45% to $8.40. The stock is going forward to its 52 week low with 17.15% and lagging behind from its 52 week high price with -55.18%. GNW last month stock price volatility remained 4.34%.Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) released that the presentation of clinical and preclinical data related to the co's immuno-oncology development program and its lead investigational immunotherapy drug candidate bavituximab at the Society for Immunotherapy of Cancer's 29th Annual Meeting and Associated Programs. Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) Trend Analysis has the market capitalization of 267.5 Million. Shares of firm climbed 0.68% to close at $1.49 with the total traded volume of 535936. The firm has current ratio of 3.90 for the most recent quarter.RSP Permian, Inc. (NYSE:RSPP) released that its third quarter earnings of $0.26 a share, excluding non-recurring items, $0.02 improved than the Capital IQ Consensus anticipates of $0.24. RSP Permian, Inc. (NYSE:RSPP) Trend Analysis stock price closed at $27.25 with the total traded volume of 1.49 Million shares. Its price to sales ratio ended at 10.27. Its market capitalization is 2.106 Billion. The stock owned by the Financial Institutions was 72.10% while by insiders was 0.40%.